Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Kemia Closes Potential $16.5M Series A To Fund Clinical Trials

Oct. 31, 2002

By Aaron Lorenzo

Neurogenetics Closes Series B With Second Tranche Of $10M

Oct. 31, 2002

By Aaron Lorenzo

Kemia Closes Potential $16.5M Series A To Fund Clinical Trials

Oct. 31, 2002

By Aaron Lorenzo

Anacor Lands $21.6M Contract, New Funding For Antimicrobials

Oct. 30, 2002

By Aaron Lorenzo

Metabasis Builds On Partnership With Sankyo Through New Deal

Oct. 30, 2002

By Aaron Lorenzo

Metabasis Builds On Partnership With Sankyo Through New Deal

Oct. 30, 2002

By Aaron Lorenzo

Anacor Lands $21.6M Contract, New Funding For Antimicrobials

Oct. 30, 2002

By Aaron Lorenzo

Peninsula Raises $22.1M To Fund In-Licensing Program

Oct. 29, 2002

By Aaron Lorenzo

Peninsula Raises $22.1M To Fund In-Licensing Program

Oct. 29, 2002

By Aaron Lorenzo

Harvard Bioscience Completes Genomics Solutions Acquisition

Oct. 28, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.